AAUM (Average Assets Under Management) of ₹1,757.36 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 17.3% | 17.6% | ▲ +0.3% |
| Auto Components | 11.1% | 11.7% | ▲ +0.6% |
| Automobiles | 10.4% | 10.6% | ▲ +0.2% |
| Food Products | 10.1% | 9.9% | ▼ -0.2% |
| Diversified FMCG | 7.5% | 7.0% | ▼ -0.5% |
| Industrial Products | 4.7% | 6.2% | ▲ +1.5% |
| Beverages | 5.2% | 5.0% | ▼ -0.2% |
| Electrical Equipment | 4.8% | 4.9% | ● +0.1% |
| IT - Software | 4.5% | 4.5% | ● +0.1% |
| Metals & Minerals Trading | 4.0% | 3.8% | ▼ -0.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 17.6% | 18.6% | ▲ +1.1% |
| Auto Components | 11.7% | 12.3% | ▲ +0.6% |
| Automobiles | 10.6% | 11.0% | ▲ +0.4% |
| Food Products | 9.9% | 9.4% | ▼ -0.5% |
| Diversified FMCG | 7.0% | 7.1% | ▲ +0.1% |
| Industrial Products | 6.2% | 6.2% | ● 0.0% |
| Electrical Equipment | 4.9% | 4.8% | ▼ -0.1% |
| Beverages | 5.0% | 4.7% | ▼ -0.2% |
| Metals & Minerals Trading | 3.8% | 3.8% | ● +0.0% |
| IT - Software | 4.5% | 3.1% | ▼ -1.5% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Vedanta Limited ₹21.06 Cr |
Diversified Metals | 1.16% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | AstraZeneca Pharma India Limited ₹19.59 Cr |
Pharmaceuticals & Biotechnology | 0.44% | 1.15% | +0.71% |
| 2 | Maruti Suzuki India Limited ₹106.10 Cr |
Automobiles | 5.67% | 6.23% | +0.56% |
| 3 | Dr. Reddy's Laboratories Limited ₹67.28 Cr |
Pharmaceuticals & Biotechnology | 3.48% | 3.95% | +0.47% |
| 4 | Sona BLW Precision Forgings Limited ₹83.13 Cr |
Auto Components | 4.50% | 4.88% | +0.38% |
| 5 | Pearl Global Industries Limited ₹47.97 Cr |
Textiles & Apparels | 2.55% | 2.82% | +0.27% |
| 6 | EPL Limited ₹29.82 Cr |
Industrial Products | 1.52% | 1.75% | +0.23% |
| 7 | Syngene International Limited ₹14.17 Cr |
Healthcare Services | 0.63% | 0.83% | +0.20% |
| 8 | Rolex Rings Limited ₹28.94 Cr |
Auto Components | 1.52% | 1.70% | +0.18% |
| 9 | Gland Pharma Limited ₹35.65 Cr |
Pharmaceuticals & Biotechnology | 1.96% | 2.09% | +0.13% |
| 10 | Kalpataru Projects International Limited ₹39.42 Cr |
Construction | 2.21% | 2.32% | +0.11% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Coforge Limited ₹14.62 Cr |
IT - Software | 2.15% | 0.86% | -1.29% |
| 2 | Nestle India Limited ₹78.11 Cr |
Food Products | 4.94% | 4.59% | -0.35% |
| 3 | Ingersoll Rand (India) Limited ₹14.50 Cr |
Industrial Products | 1.10% | 0.85% | -0.25% |
| 4 | Pfizer Limited ₹21.72 Cr |
Pharmaceuticals & Biotechnology | 1.45% | 1.28% | -0.17% |
| 5 | Anthem Biosciences Limited ₹14.46 Cr |
Pharmaceuticals & Biotechnology | 0.99% | 0.85% | -0.14% |
| 6 | Sun Pharmaceutical Industries Limited ₹69.55 Cr |
Pharmaceuticals & Biotechnology | 4.20% | 4.08% | -0.12% |
| 7 | Procter & Gamble Hygiene and Health Care Limited ₹20.55 Cr |
Personal Products | 1.33% | 1.21% | -0.12% |
| 8 | Tata Consultancy Services Limited ₹17.89 Cr |
IT - Software | 1.16% | 1.05% | -0.11% |
| 9 | Britannia Industries Limited ₹82.24 Cr |
Food Products | 4.94% | 4.83% | -0.11% |
| 10 | United Spirits Limited ₹51.66 Cr |
Beverages | 3.14% | 3.03% | -0.11% |
49 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹120.71 Cr |
Diversified FMCG |
7.09%
|
|
| 2 |
₹106.10 Cr |
Automobiles |
6.23%
|
|
| 3 |
₹83.13 Cr |
Auto Components |
4.88%
|
|
| 4 |
₹82.24 Cr |
Food Products |
4.83%
|
|
| 5 |
₹78.11 Cr |
Food Products |
4.59%
|
|
| 6 |
₹69.55 Cr |
Pharmaceuticals & Biotechnology |
4.08%
|
|
| 7 |
₹67.28 Cr |
Pharmaceuticals & Biotechnology |
3.95%
|
|
| 8 |
₹65.41 Cr |
Metals & Minerals Trading |
3.84%
|
|
| 9 |
₹64.24 Cr |
Automobiles |
3.77%
|
|
| 10 |
₹51.66 Cr |
Beverages |
3.03%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.